• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Prima BioMed Ltd

+ Add to Watchlist

PRR:AU

0.0330 AUD 0.0010 2.94%

As of 00:10:36 ET on 01/23/2015.

Snapshot for Prima BioMed Ltd (PRR)

Open: 0.0340 Day's Range: 0.0330 - 0.0350 Volume: 1,640,262
Previous Close: 0.0340 52wk Range: 0.0300 - 0.0590 1-Yr Rtn: -35.29%

Stock Chart for PRR

No chart data available.
  • PRR:AU 0.0330
  • 1D
  • 1M
  • 1Y
0.0340
Interactive PRR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRR

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0109
Est. EPS (AUD) (06/2015) -
Est. PEG Ratio -
Market Cap (M AUD) 45.86
Shares Outstanding (M) 1,389.73
30 Day Average Volume 1,560,534
Price/Book (mrq) 1.7947
Price/Sale (ttm) 2,523.0135
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRR

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PRR

Prima Biomed Ltd is an Australian biotechnology company with a portfolio of products focused in the therapeutic area of cancer.

Marc VoigtCEO/CFO/Exec DirFrederic TriebelChief Scientific Officer
Sharron GargoskyChief Technical OfficerDeanne MillerSecretary/General Counsel
More Company Profile & Key Executives for PRR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil